Axa
MDGL icon

Axa’s Madrigal Pharmaceuticals MDGL Stock Holding History

Axa’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,300
Closed -$377K – 1151
2022
Q4 		$377K Buy
+1,300
New +$127K ﹤0.01% 1021
2019
Q1 		– Sell
-4,600
Closed -$519K – 1355
2018
Q4 		$519K Sell
4,600
-1,700
-27% -$263K ﹤0.01% 1081
2018
Q3 		$1.35M Hold
6,300
– – ﹤0.01% 967
2018
Q2 		$1.76M Buy
+6,300
New +$1.11M 0.01% 888

Other funds holding MDGL

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return